Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs – AP News

betadmin

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head trial of the blockbuster weight-loss medications. Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an ave…

#stockmarket #breaking

Related Posts

Leave a Reply

WP Twitter Auto Publish Powered By : XYZScripts.com